NL-OMON49534已完成2 期
18F-PSMA-1007 PET to detect primary prostate cancer: a comparative study with mpMRI and correlation to histopathology - 18F-PSMA PET in primary prostate cancer
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Suspicion for prostate cancer (e.g. elevated PSA, suspicious rectal
- •examination)
- •- Males >= 18 years
排除标准
- •- Prostate biopsy in the last 6 months
- •- History of prostate cancer
- •- Second active malignancy
- •- Contra-indications for mpMRI or PET: claustrophobia or inability to lay still
- •for the duration of the exam.
研究者
相似试验
进行中（未招募）
1 期
18F-PSMA PET in primary prostate cancer.75 patients with the suspicion on PCa (elevated PSA and/or abnormal digital rectal exam) will receive a PSMA-PET following mpMRI. 25 patients with PIRADS 1-2 (probably benign disease), 25 patients with PIRADS 3 (equivocal disease) and 25 patients with PIRADS 4-5 (highly suspicious for malignancy) will be included in this explorative study.MedDRA version: 20.0Level: LLTClassification code 10036921Term: Prostate carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2020-001387-28-NLRadboud University Medical Center75
进行中（未招募）
1 期
PSMA-PET/CT for prostate cancerEUCTR2017-003461-96-BEGhent University Hospital72
招募中
不适用
PSMA PET prostate cancer registration studyProstate cancerNL-OMON28640-
已完成
1 期
18F-PSMA-1007 PET Imaging to Detect Primary Prostate CancerProstate CancerNCT04487847Radboud University Medical Center75
尚未招募
不适用
Prostate Cancer 18F-PSMA-1007 PET/CT Access TrialProstate CancerNCT06489496Alberta Health services1,000